Back to Search
Start Over
MERCK TAPS INDIA FOR NEW DRUG.
- Source :
-
Chemical & Engineering News . 10/23/2006, Vol. 84 Issue 43, p14-14. 1/2p. 1 Color Photograph. - Publication Year :
- 2006
-
Abstract
- The article reports on the move of Merck KGAA, a German-based pharmaceutical company, to pay US$30 million to US$240 million for rights to a diabetes drug from Glenmark Pharmaceutical, a Mumbai, India-based drug company. The deal would include Merck to develop and commercialize the diabetes drug while Glenmark will retain the rights in the country. The diabetes drug is called GRC 8200 which is dipeptidyl peptidase IV inhibitors.
- Subjects :
- *PROPERTY rights
*ASSET acquisitions
*DIABETES
*DRUGS
Subjects
Details
- Language :
- English
- ISSN :
- 00092347
- Volume :
- 84
- Issue :
- 43
- Database :
- Academic Search Index
- Journal :
- Chemical & Engineering News
- Publication Type :
- Periodical
- Accession number :
- 22933871
- Full Text :
- https://doi.org/10.1021/cen-v084n043.p014